Genetic Technologies Ltd. (GENE)

1.21
0.01 0.82
NASDAQ : Health Technology
Prev Close 1.22
Open 1.22
Day Low/High 1.20 / 1.25
52 Wk Low/High 0.70 / 2.05
Volume 35.59K
Avg Volume 89.90K
Exchange NASDAQ
Shares Outstanding 16.24M
Market Cap 19.34M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Change Of Chief Executive Officer

Change Of Chief Executive Officer

Appointment Of Chairman

Appointment Of Chairman

Resignation Of Directors

Resignation Of Directors

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are within range of breaking out and trading higher from current levels.

PHENOGEN SCIENCES SUPPORTS RESEARCH FINDING CLINICAL VALIDATION IS NEEDED FOR GENE PANEL SEQUENCING ASSOCIATED WITH HEREDITARY BREAST CANCER RISK

PHENOGEN SCIENCES SUPPORTS RESEARCH FINDING CLINICAL VALIDATION IS NEEDED FOR GENE PANEL SEQUENCING ASSOCIATED WITH HEREDITARY BREAST CANCER RISK

Clinically validated BREVAGenplus(R) more accurately identifies sporadic breast cancer risk

ROCKVILLE GYNECOLOGY NOW OFFERING BREVAGenplus(R), A STATE-OF-THE-ART TEST FOR ASSESSING BREAST CANCER RISK

ROCKVILLE GYNECOLOGY NOW OFFERING BREVAGenplus(R), A STATE-OF-THE-ART TEST FOR ASSESSING BREAST CANCER RISK

Personalized, Genetically-Based Test Enables Physicians to Tailor Breast Cancer Screening and Reduction Services Based on Individual Risk